Clinical Trial Update: A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing daily dapsone vs daily atovaquone for Pneumocystis jirovecii pneumonia prophylaxis in HIV-infected patients intolerant to TMP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Pneumocystis Pneumonia

Drugs mentioned

• Atovaquone (Atovaquone)
• DAPSONE (dapsone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED